BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Xueshan Xia, Ling Lu, Kok Keng Tee, Wenhua Zhao, Jianguo Wu, Jing Yu, Xiaojie Li, Yixiong Lin, Muhammad Mahmood Mukhtar, Curt H. Hagedorn, Yutaka Takebe. The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, ChinaJournal of Medical Virology 2008; 80(7): 1142 doi: 10.1002/jmv.21204
2
Derek R. Smith, Ning Wei, Peter A. Leggat, Rui-Sheng Wang. HIV/AIDS prevention in China: A challenge for the new millenniumEnvironmental Health and Preventive Medicine 2005; 10(3) doi: 10.1007/BF02900804
3
Víctor Granados-García, Yvonne N. Flores, Lizbeth I. Díaz-Trejo, Lucia Méndez-Sánchez, Stephanie Liu, Guillermo Salinas-Escudero, Filiberto Toledano-Toledano, Jorge Salmerón, Vincenzo De Luca. Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysisPLOS ONE 2019; 14(2): e0212558 doi: 10.1371/journal.pone.0212558
4
Xianhong Li, Guoping He, Honghong Wang, Ann Bartley Williams. Consequences of Drug Abuse and HIV/AIDS in China: Recommendations for Integrated Care of HIV-Infected Drug UsersAIDS Patient Care and STDs 2009; 23(10): 877 doi: 10.1089/apc.2009.0015
5
Don C. Des Jarlais, Heidi A. Bramson, Cherise Wong, Karla Gostnell, Javier Cepeda, Kamyar Arasteh, Holly Hagan. Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysisAddiction 2012; 107(12): 2087 doi: 10.1111/j.1360-0443.2012.04027.x
6
Yuhua Ruan, Guangming Qin, Lu Yin, Kanglin Chen, Han-Zhu Qian, Chun Hao, Shu Liang, Junling Zhu, Hui Xing, Kunxue Hong, Yiming Shao. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up studyAIDS 2007; 21(Suppl 8): S39 doi: 10.1097/01.aids.0000304695.54884.4f
7
Xian Xia, Jun Luo, Jianling Bai, Rongbin Yu. Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysisPublic Health 2008; 122(10): 990 doi: 10.1016/j.puhe.2008.01.014
8
Sheena G. Sullivan, Zunyou Wu. Rapid scale up of harm reduction in ChinaInternational Journal of Drug Policy 2007; 18(2): 118 doi: 10.1016/j.drugpo.2006.11.014
9
Yen-Jung Chang, Julie Hsieh, Ching-Yi Peng, Jianhua Li, Yih-Ing Hser. HIV and HCV Serostatus and Knowledge Among Patients in Urban Versus Rural Methadone Maintenance Clinics in KunmingJournal of Drug Issues 2014; 44(3): 281 doi: 10.1177/0022042613511438
10
Liying Ma, Yasmine Dudoit, Ton Tran, Hui Xing, Jianping Chen, Gianfranco Pancino, Georges Bismuth, Patrice Debr??, Yiming Shao, Ioannis Theodorou, Corinne Capoulade-M??tay. Biochemical and HIV-1 Coreceptor Properties of K26R, a New CCR5 Variant in China??s Sichuan PopulationJAIDS Journal of Acquired Immune Deficiency Syndromes 2005; 39(1): 38 doi: 10.1097/01.qai.0000158761.71165.e9
11
Nitin K SAKSENA, Bin WANG, Megan STEAIN, Rong Ge YANG, Lin Qi ZHANG. Snapshot of HIV pathogenesis in ChinaCell Research 2005; 15(11-12): 953 doi: 10.1038/sj.cr.7290373
12
Y-P Bao, Z-M Liu. Systematic review of HIV and HCV infection among drug users in ChinaInternational Journal of STD & AIDS 2009; 20(6): 399 doi: 10.1258/ijsa.2008.008362
13
Yuan Dong, Chao Qiu, Xueshan Xia, Jing Wang, Haiyan Zhang, Xiaoyan Zhang, Jianqing Xu. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional studyArchives of Virology 2015; 160(4): 929 doi: 10.1007/s00705-014-2311-0
14
Doris B. Strader. Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority PopulationsClinical Infectious Diseases 2005; 41(Supplement_1): S7 doi: 10.1086/429489
15
Wei Liu, Jie Chen, Michelle Rodolph, Geetha Beauchamp, Benoît Mâsse, Shaoping Wang, Rongjian Li, Yuhua Ruan, Feng Zhou, Man-kit Leung, Shenghan Lai, Yiming Shao, J. Brooks Jackson. HIV prevalence among injection drug users in rural Guangxi ChinaAddiction 2006; 101(10): 1493 doi: 10.1111/j.1360-0443.2006.01557.x
16
Corina Lelutiu-Weinberger, Enrique R. Pouget, Don D.C. Des Jarlais, Hannah L. Cooper, Roberta Scheinmann, Rebecca Stern, Shiela M. Strauss, Holly Hagan. A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groupsSocial Science & Medicine 2009; 68(3): 579 doi: 10.1016/j.socscimed.2008.10.011
17
Ying Shi, Ya Yang, Yingjian Wang, Dongjian Yang, Yu Yang, Shurong Dong, Chunlin Li, Yue Chen, Qingwu Jiang, Yibiao Zhou. Prevalence and associated factors of Treponema pallidum infection in a rural area of southwestern ChinaBMC Public Health 2020; 20(1) doi: 10.1186/s12889-020-08952-7
18
Tomas Zabransky, Viktor Mravcik, Blanka Korcisova, Vratislav Rehak. Hepatitis C Virus Infection among Injecting Drug Users in the Czech Republic – Prevalence and Associated FactorsEuropean Addiction Research 2006; 12(3): 151 doi: 10.1159/000092117
19
Nana Wu, Qinjuan Ge, Qingchuan Feng, Jun Zhang, Xiaoxia Liu, Caihong Sun, Yongkang Xu, Guangli He, Chiyu Zhang. High Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, ChinaIndian Journal of Virology 2011; 22(2): 77 doi: 10.1007/s13337-011-0041-4
20
Joseph T.F. Lau, Jing Gu, Linglin Zhang, Feng Cheng, Yun Zhang, Jianxin Zhang, Ning Wang, Yajia Lan. Comparing prevalence of HIV-related behaviors among female injecting drug users (IDU) whose regular sexual partner was or was not IDU in Sichuan and Yunnan Provinces, ChinaAIDS Care 2009; 21(7): 909 doi: 10.1080/09540120802612790
21
Holly Hagan, Don C. Des Jarlais, Rebecca Stern, Corina Lelutiu-Weinberger, Roberta Scheinmann, Shiela Strauss, Peter L. Flom. HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injectionInternational Journal of Drug Policy 2007; 18(5): 341 doi: 10.1016/j.drugpo.2007.01.016
22
Don C. Des Jarlais, Jonathan P. Feelemyer, Shilpa N. Modi, Kamyar Arasteh, Holly Hagan. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: An international systematic review of high seroprevalence areasDrug and Alcohol Dependence 2012; 124(1-2): 95 doi: 10.1016/j.drugalcdep.2011.12.020
23
Rebecca J. Garten, Jinbing Zhang, Shenghan Lai, Wei Liu, Jie Chen, Xiao-Fang Yu. Coinfection with HIV and Hepatitis C Virus among Injection Drug Users in Southern ChinaClinical Infectious Diseases 2005; 41(Supplement_1): S18 doi: 10.1086/429491
24
Derek R. Smith, Ning Wei, Peter A. Leggat, Rui-Sheng Wang. HIV/AIDS prevention in China: A challenge for the new millenniumEnvironmental Health and Preventive Medicine 2005; 10(3) doi: 10.1007/BF02900804
25
Y. Hser, J. Du, J. Li, M. Zhao, Y. J. Chang, C. Y. Peng, E. Evans. Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, ChinaJournal of Public Health 2012; 34(1): 24 doi: 10.1093/pubmed/fdr098
26
Guoping Du, Xiaoshan Li, Taha Hussein Musa, Yu Ji, Bo Wu, Yan He, Qian Ni, Ling Su, Wei Li, You Ge. The nationwide distribution and trends of hepatitis C virus genotypes in mainland ChinaJournal of Medical Virology 2019; 91(3): 401 doi: 10.1002/jmv.25311
27
T. Hussain, K.K. Kulshreshtha, Shikha Sinha, V.S. Yadav, V.M. Katoch. HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern IndiaInternational Journal of Infectious Diseases 2006; 10(5): 358 doi: 10.1016/j.ijid.2005.09.005
28
Yu Liu, Juncheng Liang, Chengzheng Zhao, Wenhua Zhou. Looking for a solution for drug addiction in China: Exploring the challenges and opportunities in the way of China's new Drug Control LawInternational Journal of Drug Policy 2010; 21(3): 149 doi: 10.1016/j.drugpo.2009.10.002